N-methoxy-benzylpenicillinamide

Beta-lactam (penicillin)
Hofimann-La Roche Inc
1967
  • Highest development stage: Preclinical

  • Development dropped

  • Gram-positive activity

  • Mechanism of Action/Target pathogen: Modified penicillin, Cell wall biosynthesis target.

  • Additional information: Grunberg, E and Beskid G. 1967. "Chemotherapuetic properties of N-Alkoxyamide Derivatives of Penicillin." ICAAC Conference.

  • Source: http://www.google.com/patents/US3177203